Parkway Wealth Management Group »

Arrowhead Pharmaceuticals shares owned by Parkway Wealth Management Group

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Parkway Wealth Management Group from 13F filings

Historical chart of Parkway Wealth Management Group investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Parkway Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Parkway Wealth Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $414k 6.2k 66.39

More positions owned by Parkway Wealth Management Group

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Etf Ser Solutions Defiance Quantum (QTUM)
Global X Fds Defense Tech Etf (SHLD)
Ishares Tr Msci Euro Fl Etf (EUFN)
Ishares Msci Italy Etf (EWI)
Ark Etf Tr Innovation Etf (ARKK)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Rus Mdcp Val Etf (IWS)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Global X Fds Global X Uranium (URA)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Tips Bd Etf (TIP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Series Trust State Street Spd (SPYG)

View all positions for Parkway Wealth Management Group

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Slate Path Capital
Geode Capital Management
Siren
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Marshall Wace
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals